Navigation Links
CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010
Date:9/16/2010

WASHINGTON, Sept. 16 /PRNewswire/ -- CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010.  The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".

Some of the highlights of the presentation will include an exploration of the clinical benefits of CID's Abluminal Reservoir Technology (ART) and drug delivery technology. By surrounding molecules of drug with amphiphilic carriers and embedding them into reservoirs on the stent's outer surface, CID drug-eluting stents are able to deliver drug to the coronary arteries without using any polymers, which can cause serious complications in patients.

CID's unique ART system with its amphiphilic carrier is more physiological and patients who receive these stents are less likely to have inflammation and thrombosis within their coronary arteries. Moreover CID DES technology features an integral Bio-Inducer Surface (BIS) which implies less medication to prevent blood clotting after the stent has been deployed for enhanced safety.

Commenting on the innovative technology in its new Cre8 DES, Franco Vallana, Chief Executive Officer of CID s.r.l. said, "We have always known that the more the stent and the drug delivery system are designed and developed to harmonize with the human body, the better the short- and long-term results will be. Combining ART with our innovative drug formulation with amphiphilic carrier into a completely polymer-free stent will allow doctors to provide their patients with stents that are more physiological and complement the body's natural systems."


'/>"/>
SOURCE CID s.r.l.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vista Partners Updates Coverage on Raptor Pharmaceutical Corp.
2. Encorium Group, Inc. Provides Update on Its Previously Announced Rights Offering
3. Shire Update on ProAmatine(R) (midodrine HCl)
4. Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Cobalis Corp. Provides Marketing Update Conference Call for Investors
7. China Sky One Medical Updates Financial Guidance for 2010
8. Halozyme Provides HYLENEX® Product Reintroduction Update
9. Personalized Medicine: Conference Provides Update on Progress and Prospects
10. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
11. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):